- Study Lead: Gianmario Candore
- Analytics Use Case: Characterization
- Study Start Date: 2023-06-01
- Study End Date: 2099-12-31
- Study Tags: None
- Protocol: Unavailable
- Publications: Unavailable
- Results Explorer: Unavailable
- Bayer
- Gianmario Candore
- Sirr Su Saydam
- Oxford
- Marta Pineda Moncusi
- Odysseus Data Services
- Asieh Golozar
- Martin Lavallee
- George Argyriou
- Boehringer Ingelheim
- Ron Herrera
EHDEN HMB is a characterization study of a heavy-menstrual bleeding cohort conducted on EHDEN network databases that have been standardized to the OMOP CDM.
This study will be run on OMOP databases in the EHDEN Network. The table below lists some of the data partners that will participate in this study.
| Database | Country | Responsible Party |
|---|---|---|
| CPRD GOLD | UK | Bayer |
| CPRD AURUM | UK | Bayer |
| Optum Clinformatics | US | Bayer |
| MarketScan IBM | US | Bayer |
| Cegedim THIN | Belgium | Boehringer Ingelheim |
| Disease Analyzer | Germany | Boehringer Ingelheim |
| Hospital del Mar (Barcelona) | Spain | Hospital del Mar |
| Semmelweis University | Hungary | Semmelweis University |
| Helsinksi University Hospital | Finland | Helsinksi University |
| NLHR@UIO | Norway | University of Oslo |